Medi Assist Healthcare Intrinsic Value
Medi Assist Healthcare intrinsic value. Medi Assist Healthcare (MEDIASSIST) median intrinsic value is ₹330.81 from 9 valuation models (range ₹188–₹594), vs current price ₹297.20 — +11.3% upside (Trading Below Median Value), margin of safety 10.2%. Compare with MEDIASSIST stock valuation models to assess whether the stock is under or overvalued.
MEDIASSIST Valuation Methods Summary — DCF, Graham Number & P/E
Medi Assist Healthcare intrinsic value across 9 models vs current price ₹297.20 — upside/downside and value range per method. Read MEDIASSIST dividend payout details for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹351.84 | ₹281.47 - ₹422.21 | +18.4% | EPS: ₹29.32, Sector P/E: 12x |
| Book Value Method | asset | ₹226.76 | ₹204.08 - ₹249.44 | -23.7% | Book Value/Share: ₹226.76, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹211.89 | ₹190.70 - ₹233.08 | -28.7% | Revenue/Share: ₹264.86, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹330.81 | ₹297.73 - ₹363.89 | +11.3% | EBITDA: ₹204.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹346.26 | ₹277.01 - ₹415.51 | +16.5% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹187.65 | ₹168.89 - ₹206.42 | -36.9% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹241.60 | ₹217.44 - ₹265.76 | -18.7% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹594.40 | ₹534.96 - ₹653.84 | +100.0% | ROE: 26.2%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹386.77 | ₹348.09 - ₹425.45 | +30.1% | EPS: ₹29.32, BVPS: ₹226.76 |
MEDIASSIST Intrinsic Value vs Market Price — All Valuation Models
Medi Assist Healthcare fair value range ₹188–₹594 vs current market price ₹297.20 across 9 valuation models. For current market price and key ratios, visit Medi Assist Healthcare screener.
MEDIASSIST Intrinsic Value Analysis — Undervalued or Overvalued?
Medi Assist Healthcare median intrinsic value ₹330.81, current price ₹297.20 — Trading Below Median Value by 11.3%, margin of safety 10.2%.
What is the intrinsic value of MEDIASSIST?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Medi Assist Healthcare (MEDIASSIST) is ₹330.81 (median value). With the current market price of ₹297.20, this represents a +11.3% variance from our estimated fair value.
The valuation range spans from ₹187.65 to ₹594.40, indicating ₹187.65 - ₹594.40.
Is MEDIASSIST undervalued or overvalued?
Based on our multi-method analysis, Medi Assist Healthcare (MEDIASSIST) appears to be trading below median value by approximately 11.3%.
MEDIASSIST Financial Health — Key Ratios vs Industry Benchmarks
Medi Assist Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.13 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 26.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.71x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
MEDIASSIST Cash Flow Quality — Operating & Free Cash Flow
Medi Assist Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹138 Cr | ₹29 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹66 Cr | ₹39 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹81 Cr | ₹76 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹64 Cr | ₹23 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹139 Cr | ₹109 Cr | Positive Free Cash Flow | 8/10 |